Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
HilleVax (NASDAQ:HLVX) reported quarterly losses of $(0.83) per share which missed the analyst consensus estimate of $(0.43) by 93.02 percent. This is a 12.16 percent decrease over losses of $(0.74) per share from the same period last year.
$245.0 million of cash, cash equivalents and marketable securities as of June 30, 2024
Posted In: HLVX